These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8704197

  • 21. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
    Farese AM, MacVittie TJ, Roskos L, Stead RB.
    Stem Cells; 2003; 21(1):79-89. PubMed ID: 12529554
    [Abstract] [Full Text] [Related]

  • 22. Recombinant human megakaryocyte growth and development factor attenuates postbypass thrombocytopenia.
    Nakamura M, Toombs CF, Duarte IG, Ronson RS, Schmarkey LS, Katzmark SL, Robinson J, Dillehay DL, Vinten-Johansen J, Guyton RA.
    Ann Thorac Surg; 1998 Oct; 66(4):1216-23. PubMed ID: 9800809
    [Abstract] [Full Text] [Related]

  • 23. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.
    Yan XQ, Hartley C, McElroy P, Chang A, McCrea C, McNiece I.
    Blood; 1995 May 01; 85(9):2303-7. PubMed ID: 7537109
    [Abstract] [Full Text] [Related]

  • 24. The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.
    Ulich TR, del Castillo J, Senaldi G, Cheung E, Roskos L, Young J, Molineux G, Guo J, Schoemperlen J, Munyakazi L, Murphy-Filkins R, Tarpley JE, Toombs CF, Kaufman S, Yin S, Nelson AG, Nichol JL, Sheridan WP.
    Exp Hematol; 1999 Jan 01; 27(1):117-30. PubMed ID: 9923450
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors.
    Liu Yin JA, Adams JA, Brereton ML, Hann A, Harrison BD, Briggs M.
    Br J Haematol; 2000 Mar 01; 108(4):743-6. PubMed ID: 10792278
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 31. Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice.
    Akahori H, Ozai M, Ida M, Shibuya K, Kato T, Miyazaki H.
    Ther Apher; 1998 Feb 01; 2(1):58-64. PubMed ID: 10227790
    [Abstract] [Full Text] [Related]

  • 32. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
    Hassan HT, Zander AR.
    J Hematother; 1996 Aug 01; 5(4):407-14. PubMed ID: 8877716
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
    Adams JA, Liu Yin JA, Brereton ML, Briggs M, Burgess R, Hyde K.
    Br J Haematol; 1997 Oct 01; 99(1):139-46. PubMed ID: 9359514
    [Abstract] [Full Text] [Related]

  • 35. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.
    Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB.
    Blood; 1998 Jun 15; 91(12):4427-33. PubMed ID: 9616135
    [Abstract] [Full Text] [Related]

  • 36. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 37. Decreased prothrombotic effects of pegylated recombinant human megakaryocyte growth and development factor in thrombocytopenic state in a rat thrombosis model.
    Nishiyama U, Kuwaki T, Akahori H, Kato T, Ikeda Y, Miyazaki H.
    J Thromb Haemost; 2005 Feb 15; 3(2):355-60. PubMed ID: 15670044
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.